More to Drug Story 

Dale Brumfield's Back Page piece on Avastin (“Obama's Drug War,” Jan. 19) shows a strong political bias; after doing some research you will see a different perspective. Business Week's article on the subject stated: “Avastin was approved for breast cancer in February 2008 based on preliminary evidence suggesting it slowed disease progression. Two follow-up trials showed Avastin didn't prolong survival in women with breast cancer or improve symptoms, and the drug had a smaller effect on tumor growth than the Food and Drug Administration had expected. The agency decided the benefits didn't outweigh potential risks of serious bleeding, heart attacks and kidney damage.” I believe the FDA is supposed to determine the safety of food and drugs, so it appears it is just doing its job.
Kathy Kurtz


Subscribe to this thread:

Add a comment

Connect with Style Weekly

Most Popular Stories

  • OPINION: School Board Drama

    OPINION: School Board Drama

    Campaign contributions from vendors doing business with the city smacks of Tammany Hall corruption. If we are going to do right by the children in our city, we need to stop playing politics.
    • Jun 15, 2021
  • OPINION: Privatizing Creighton

    OPINION: Privatizing Creighton

    Welcome to public housing without the public part. It’s time to demand that RRHA provides more of a commitment to residents.
    • May 25, 2021
  • Week of June 9

    Week of June 9

    • Jun 9, 2021
  • OPINION: Reopen Safely, Rebuild Now

    OPINION: Reopen Safely, Rebuild Now

    George Wythe High School urgently needs rebuilding. The Richmond School Board should be focused on reopening schools, not taking over school construction.
    • May 18, 2021
  • More »

Copyright © 2021 Style Weekly
Richmond's alternative for news, arts, culture and opinion
All rights reserved
Powered by Foundation